Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Charles E. Geyer Jr"'
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 21, Iss 4, Pp 517-530 (2020)
The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness, hospitalizations, and death. The complex and multifaceted pathophysiology of life-threatening COVID-19 illness including viral mediated organ damage, cytokine stor
Externí odkaz:
https://doaj.org/article/55365a581aca443eaca2bf710a0a06f8
Autor:
Katherine L. Pogue-Geile, Sai K. Maley, Rim S. Kim, Ying Wang, Roberto Salgado, Corey Lipchik, Huichen Feng, Reena S. Cecchini, Samuel A. Jacobs, Ashok Srinivasan, Eleftherios (Terry) Mamounas, Charles E. Geyer Jr, Priya Rastogi, C. Kent Osborne, Soonmyung Paik, Norman Wolmark, Peter C. Lucas, Mothaffar Rimawi
Publikováno v:
Cancer Research. 83:P1-04
Background: The primary aim of the NRG Oncology/NSABP B-52 clinical trial was to test if estrogen deprivation (ED) administered concomitantly with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab (TCHP), would improve the pCR rate in p
Autor:
Charles E. Geyer, Jr, Gong Tang, Priya Rastogi, Vicente Valero, Stephen K. Chia, Erin F. Cobain, Elias Obeid, David B. Page, Andrew S. Poklepovic, William J. Irvin, Jr., Adam M. Brufsky, Irene L. Wapnir, Jennifer M. Suga, Eleftherios (Terry) Mamounas, Norman Wolmark
Publikováno v:
Cancer Research. 83:OT2-16
Background: The CLEOPATRA trial established trastuzumab, pertuzumab and a taxane (THP) as a standard of care for first line metastatic, HER2-positve breast cancer with median progression-free survival (PFS) of 18.7 months and median OS of 57 months.
Autor:
Peter Schmid, Charles E. Geyer Jr, Nadia Harbeck, Mothaffar Rimawi, Sara Hurvitz, Miguel Martín, Sherene Loi, Shigehira Saji, Kyung Hae Jung, Gustavo Werutsky, Daniil L. Stroyakovsky, Vanesa López-Valverde, Michael Davis, Tanja Badovinac Crnjevic, Pablo D. Perez-Moreno, Aditya Bardia
Publikováno v:
Cancer Research. 83:OT2-03
BACKGROUND Endocrine therapies (ETs) that target estrogen receptor (ER) activity and/or estrogen synthesis are the mainstay of ER+ breast cancer (BC) treatment. Despite best management, ≤20% of patients (pts) with ER+/HER2– early BC (eBC) develop
Publikováno v:
Breast Cancer Research & Treatment; May2004, Vol. 85 Issue 2, p143-150, 8p
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer.
Autor:
O'Regan, Ruth M., Zhang, Yi, Fleming, Gini F., Francis, Prudence A., Kammler, Roswitha, Viale, Giuseppe, Dell'Orto, Patrizia, Lang, Istvan, Bellet, Meritxell, Bonnefoi, Herve R., Tondini, Carlo, Villa, Federica, Bernardo, Antonio, Ciruelos, Eva M., Neven, Patrick, Karlsson, Per, Müller, Bettina, Jochum, Wolfram, Zaman, Khalil, Martino, Silvana
Publikováno v:
JAMA Oncology; Oct2024, Vol. 10 Issue 10, p1379-1389, 11p
Autor:
Mamounas, Eleftherios P, Bandos, Hanna, Rastogi, Priya, Lembersky, Barry C, Jeong, Jong-Hyeon, Geyer, Charles E, Fehrenbacher, Louis, Chia, Stephen K, Brufsky, Adam M, Walshe, Janice M, Soori, Gamini S, Dakhil, Shaker R, Wade, James L, McCarron, Edward C, Swain, Sandra M, Wolmark, Norman
Publikováno v:
JNCI: Journal of the National Cancer Institute; Nov2023, Vol. 115 Issue 11, p1302-1309, 8p
Autor:
Starr, Phoebe
Publikováno v:
Oncology Practice Management. Mar2019, Vol. 9 Issue 3, p43-44. 2p.
Publikováno v:
NPJ Breast Cancer; 6/23/2023, Vol. 9 Issue 1, p1-9, 9p
Autor:
Rastogi, Priya, Tang, Gong, Hassan, Saima, Geyer Jr, Charles E., Azar, Catherine A., Magrinat, Gustav C., Suga, J. Marie, Bear, Harry D., Baez-Diaz, Luis, Sarwar, Shakir, Boileau, Jean-Francois, Brufsky, Adam M., Shibata, Henry R., Bandos, Hanna, Paik, Soonmyung, Yothers, Greg, Swain, Sandra M., Mamounas, Eleftherios P., Wolmark, Norman
Publikováno v:
Breast Cancer Research & Treatment; Jun2023, Vol. 199 Issue 2, p243-252, 10p